Loading
Combine registry cancer incidence by district with open trial site locations from ClinicalTrials.gov to map the regions where patients live more than an hour from any trial. Sponsors and funders would use it to decide where to open sites and justify site selection in diversity plans.
An open, regularly updated geospatial dataset joins registry incidence (by county or district) with trial site locations and recruitment status from ClinicalTrials.gov and other registries, producing an index of trial access by disease, with travel-time isochrones and demographic overlays. Sponsors are asked to justify site selection against the map in diversity plans.
Shares Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018, GLOBOCAN / Global Cancer Observatory, SEER (Surveillance, Epidemiology, and End Results), ClinicalTrials.gov.
Shares GLOBOCAN / Global Cancer Observatory, SEER (Surveillance, Epidemiology, and End Results), International Agency for Research on Cancer (IARC / WHO), Data silos.
Shares Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018, Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018, Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018, Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018, Trials do not represent the people who get cancer, Trials enrol too few, too slowly.
Shares GLOBOCAN / Global Cancer Observatory, International Agency for Research on Cancer (IARC / WHO), Data silos.
Shares GLOBOCAN / Global Cancer Observatory, International Agency for Research on Cancer (IARC / WHO), Data silos.